You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Regulation Impact Statement: Regulation of herbal and homoeopathic medicines
This consultation closed on 15 August 2006
This Regulation Impact Statement (RIS) was prepared to address the changes that are proposed in the draft Medicines Rule, to the way in which herbal and homoeopathic medicines are currently regulated in Australia.
The draft Medicines Rule was published for consultation on 23 May 2006 on the ANZTPA Internet site.
Stakeholders were invited to provide written comment on this Consultation (Draft) Regulation Impact Statement.
In particular, stakeholders were asked to comment on the costs and benefits of the proposed and alternative options including:
- effects on small business and restrictions on competition;
- the effect that the proposed regulation would have on the supply of affected products;
- the time and cost imposts on industry;
- the effects of any perceived increase in the complexity of regulatory requirements; and
- a quantification of compliance costs (particularly from Homoeopathic manufacturers and importers in relation to GMP).
- Overall assessment of costs
- Regulation of homoeopathic medicines
- Regulation of herbal medicines